Abstract

While it may be best to avoid any therapies during pregnancy, when treatment is necessary, several options exist. Most topical therapies pose little risk during pregnancy with the notable exception of tazarotene. Phototherapy with broad-band UVB or narrow-band UVB is probably as safe as sunlight. PUVA is rated pregnancy category C because of its mechanism of action. Of the currently available oral medications, methotrexate and acitretin are clearly teratogenic, while cyclosporine appears to be the safest of these medications. With the introduction of biologic agents, we now have many new therapies that may be safely administered during pregnancy if psoriasis is severe.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.